Providing pharmacy services during the coronavirus pandemic

被引：124
作者：
Liu, Shao [1 ,2 ]
Luo, Ping [1 ,2 ]
Tang, Mimi [1 ,2 ]
Hu, Qin [1 ,2 ]
Polidoro, Joseph P. [3 ]
Sun, Shusen [1 ,2 ,3 ]
Gong, Zhicheng [1 ,2 ]
机构：
[1] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha 410008, Hunan, Peoples R China
[2] Hunan Inst Pharm Practice & Clin Res, Changsha 410008, Hunan, Peoples R China
[3] Western New England Univ, Dept Pharm Practice, Coll Pharm & Hlth Sci, Springfield, MA 01119 USA
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2020年 / 42卷 / 02期
关键词：
China; Coronavirus; COVID-19; Pharmaceutical care; Pharmacists; Pharmacy service; Public health;
D O I：
10.1007/s11096-020-01017-0
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The coronavirus disease 19 (COVID-19) is quickly spreading across China and globally. Pharmacy services are an important pillar in public health to prevent and contain the COVID-19 pandemic. Chinese pharmacists have acted swiftly in the public health response in China, such as drafting professional service guidance to pharmacists and pharmacies, establishing emergency drug formularies, monitoring and resolving drug shortages, establishing remote pharmacy services to prevent human-to-human infections, providing event-driven pharmaceutical care, educating the public on infection prevention and disease management, and participating in clinical trials and drug evaluation. This commentary reviews the unique needs of pharmacy services in the COVID-19 pandemic, and shares our experiences with the international pharmacy community in the response to these needs.
引用
收藏
页码：299 / 304
页数：6
相关论文
共 14 条
[1]  
[Anonymous], 2020, J. Infect, DOI DOI 10.1016/J.JINF.2020.02.010
[2]  
China National Health Commission, DIAGN TREATM GUID NE
[3]  
China State Council, NOT STAND MED I COND
[4]  
Fox Erin R, 2018, Am J Health Syst Pharm, V75, P1742, DOI 10.2146/ajhp180441
[5]  
International Pharmaceutical Federation (FIP), SRAS COV 2 OUTBR PRE
[6]  
Liu S, 2020, CHIN J HOSP PHARM, V40, P243, DOI DOI 10.13286/j.1001-5213.2020.03.01
[7]   SLEW OF TRIALS LAUNCH TO TEST CORONAVIRUS TREATMENTS IN CHINA [J].
Maxmen, Amy .
NATURE, 2020, 578 (7795) :347-348
[8]   Combating drug shortages in China: surveillance warning and practice standardization [J].
Shi, Yin ;
Yang, Ping ;
Li, Xiangping ;
Lv, Jinfeng ;
Yin, Tao ;
Gong, Zhicheng ;
Sun, Shusen ;
Zhou, Boting .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (02) :309-314
[9]  
The Chinese Pharmaceutical Association, COR SARS COV 2 INF E
[10]  
The Lancet, 2020, Lancet, V395, P537, DOI 10.1016/S0140-6736(20)30379-2
12